Transfer of Technology

Eli Lilly

Multi-Drug Resistant Tuberculosis can require long-term treatment with multiple drugs. Eli Lilly and its partners have identified a need for reliable generic suppliers in developing countries. Lilly's technology transfer programme aims to give free drug manufacturing know-how to manufacturing firms in MDR-TB hot spots. Global Health TV reports from South Africa where Lilly has been working with Aspen Pharmacare to ensure access to care and treatment for those who need it most.